Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature
Abstract Background Immune checkpoint inhibitors avoid inhibition of T-cell responses, upregulating antitumor immune response. Moreover, a dysregulation with hyperactive immune response can be caused, some of them underdiagnosed. Hemophagocytic lymphohistiocytosis is a rare and often fatal syndrome...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2022-10-01
|
| coleção: | Journal of Medical Case Reports |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13256-022-03585-3 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|